enVVeno Medical Corporation
NVNO
$2.48
-$0.11-4.25%
| Weiss Ratings | NVNO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | NVNO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NVNO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.65 | |||
| Price History | NVNO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -15.65% | |||
| 30-Day Total Return | -35.08% | |||
| 60-Day Total Return | -27.91% | |||
| 90-Day Total Return | -26.41% | |||
| Year to Date Total Return | -19.22% | |||
| 1-Year Total Return | -51.66% | |||
| 2-Year Total Return | -48.55% | |||
| 3-Year Total Return | -61.85% | |||
| 5-Year Total Return | -66.10% | |||
| 52-Week High % Change | -60.03% | |||
| 52-Week Low % Change | 5.71% | |||
| Price | NVNO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $6.48 | |||
| 52-Week Low Price | $2.45 | |||
| 52-Week Low Price (Date) | Dec 20, 2024 | |||
| 52-Week High Price (Date) | Jul 16, 2024 | |||
| Valuation | NVNO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 45.42M | |||
| Enterprise Value | 3.33M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.40 | |||
| Earnings Per Share Growth | -35.27% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 1.08 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $2.48 | |||
| Enterprise Value/EBITDA (TTM) | -0.14 | |||
| Enterprise Value/EBIT | -0.14 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | NVNO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 20.38M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NVNO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 949 261 2900 | |||
| Address | 70 Doppler Irvine, CA 92618 | |||
| Website | www.envveno.com | |||
| Country | United States | |||
| Year Founded | 1999 | |||
| Profitability | NVNO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | NVNO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -31.82% | |||
| Return on Equity | -- | |||
| Income Statement | NVNO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -23.64M | |||
| EBIT (TTM) | -23.83M | |||
| Net Income (TTM) | -21.82M | |||
| Net Income Avl. to Common (TTM) | -21.82M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -10.27% | |||
| EPS Diluted (TTM) | -1.40 | |||
| EPS Diluted Growth (Q YOY) | 16.06% | |||
| Balance Sheet | NVNO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 43.15M | |||
| Cash Per Share (Q) | $2.12 | |||
| Total Current Assets (Q) | 43.73M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 42.16M | |||
| Current Ratio (Q) | 20.875 | |||
| Book Value Per Share (Q) | $2.40 | |||
| Total Assets (Q) | 44.95M | |||
| Total Current Liabilities (Q) | 2.10M | |||
| Total Debt (Q) | 1.06M | |||
| Total Liabilities (Q) | 2.80M | |||
| Total Common Equity (Q) | 42.16M | |||
| Cash Flow | NVNO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 1.34M | |||
| Cash from Financing (TTM) | 13.64M | |||
| Net Change in Cash (TTM) | -1.87M | |||
| Levered Free Cash Flow (TTM) | -10.70M | |||
| Cash from Operations (TTM) | -16.84M | |||
